COMPANY
Lynch Biologics
FDA-cleared device company Past trials only
Timeline
- Trial start Phase 2: Evaluation of ABSOLVE in Diabetic Foot Ulcers source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03037970 | Evaluation of ABSOLVE in Diabetic Foot Ulcers | Phase 2 | Unknown status (ClinicalTrials.gov) | Jan 30, 2017 | Aug 15, 2017 (estimated) |